GLP-1 tells your gut to slow down
A double-blind, placebo-controlled trial allocated women with active IIH to 12-week dosing of either placebo ( n = 7) or exenatide ( n = 7), a GLP-1R agonist [27]
During a 72-week trial, participants saw a substantial and sustained reduction in body weight by taking tirzepatide, regardless of the drug dosage, a 2022 study found
Glutathione is often combined with other nutrients for antioxidant, skin or detox focused protocols
How retatrutide is thought to work Retatrutide's defining feature is that it is a triple agonist , acting on three receptors that each play a role in metabolism: the GLP-1 receptor , the GIP receptor , and the glucagon receptor
GLP-1 agonists address the insulin resistance mechanism directly, and several studies have documented period regularization in women with PCOS on GLP-1 therapy